Contact this trialFirst, we need to learn more about you.
siRNA
Pozelimab + Cemdisiran for Myasthenia Gravis
Recruiting1 awardPhase 3
Colorado Springs, Colorado
This trial is testing a combination of two drugs, pozelimab and cemdisiran, to see if it improves daily functioning in people with myasthenia gravis. The secondary objectives are to see if the combination improves symptoms of myasthenia gravis, muscle strength, quality of life, and more. The trial will also assess the safety and side effects of the combination.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.